PDF herunterladen
Aktuelle Neurologie 2007; 34(1): 40-48
DOI: 10.1055/s-2006-951799
Fort- und Weiterbildung
© Georg Thieme Verlag KG Stuttgart · New York

Thrombolyse im 3- bis 6-Stunden-Zeitfenster nach Schlaganfall

Thrombolytic Therapy within 3 to 6 Hours after Onset of Ischemic StrokeC.  Weimar1 , R.  Weber1 , Z.  Katsarava1 , H.-C.  Diener1
  • 1
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
01. Februar 2007 (online)

Auch verfügbar auf
    Lizenzen und Reprints

Weiterbildungsziele

Randomisierte Studien zur Lysebehandlung nach Schlaganfall Effektivität und mögliche Indikationen einer systemischen Lysebehandlung im Zeitfenster zwischen 3 - 6 h nach Schlaganfall Effektivität und mögliche Indikationen einer intraarteriellen Lysebehandlung im Zeitfenster zwischen 3 - 6 h nach Schlaganfall Laufende Studien zur Erweiterung des Behandlungszeitfensters der Fibrinolyse bei Schlaganfall Praktisches Vorgehen und Perspektiven der Lysebehandlung

Literatur

  • 1 Heuschmann P U, Berger K, Misselwitz B. et al . Frequency of thrombolytic therapy in patients with acute ischemic stroke and the risk of in-hospital mortality: the German Stroke Registers Study Group.  Stroke. 2003;  34 1106-1113
    CrossrefPubMedGoogle Scholar
  • 2 Hill M D, Buchan A M. Thrombolysis for acute ischemic stroke: results of the Canadian Alteplase for Stroke Effectiveness Study.  CMAJ. 2005;  172 1307-1312
    CrossrefPubMedGoogle Scholar
  • 3 Reed S D, Cramer S C, Blough D. et al . Treatment with tissue plasminogen activator and inpatient mortality rates for patients with ischemic stroke treated in community hospitals.  Stroke. 2001;  32 1832-1840
    PubMedGoogle Scholar
  • 4 Hommel M, Boissel P, Cornu C. et al . Termination of trial of streptokinase in severe acute ischemic stroke.  Lancet. 1995;  345 357
    CrossrefPubMedGoogle Scholar
  • 5 Multicenter Acute Stroke Trial-Italy (MAST-I) Group . Randomised controlled trial of streptokinase, aspirin and combination of both in treatment of acute ischemic stroke.  Lancet. 1995;  346 1509-1514
    PubMedGoogle Scholar
  • 6 Donnan G A, Hommel M, Davis S M, McNeil J J. Streptokinase in acute ischaemic stroke. Steering Committees of the ASK and MAST-E trials. Australian Streptokinase Trial.  Lancet. 1995;  346 56
    PubMedGoogle Scholar
  • 7 The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group . Tissue plasminogen activator for acute ischemic stroke.  N Engl J Med. 1995;  333 1581-1587
    CrossrefPubMedGoogle Scholar
  • 8 Hacke W, Kaste M, Fieschi C. et al. for the ECASS Study Group . Intravenous thrombolysis with recombinant tissue plasminogen activator for of acute hemispheric stroke. The European cooperative acute stroke study (ECASS).  JAMA. 1995;  274 1017-1025
    CrossrefPubMedGoogle Scholar
  • 9 Hacke W K, Fieschi M, Kummer C von. et al. for the Second European-Australasian Acute Stroke Study Investigators . Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II).  Lancet. 1998;  352 1245-1251
    CrossrefPubMedGoogle Scholar
  • 10 Clark W, Wissman S, Albers G. et al., for the ATLANTIS Study Investigators . Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset - The ATLANTIS Study: A randomized controlled trial.  JAMA. 1999;  282 2019-2026
    CrossrefPubMedGoogle Scholar
  • 11 Hacke W, Kaste M, Fieschi C. et al . Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke.  JAMA. 1995;  274 1017-1025
    CrossrefPubMedGoogle Scholar
  • 12 Hacke W, Donnan G, Fieschi C. et al., ATLANTIS Trials Investigators, ECASS Trials Investigators, NINDS rt-PA Study Group Investigators . Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials.  Lancet. 2004;  363 768-774
    CrossrefPubMedGoogle Scholar
  • 13 Third international stroke trial (IST-3). In: Goldberg MP (ed) Stroke Trials Directory. Internet Stroke Center web site. 07-Aug-2006: http://www.strokecenter.org/trials/TrialDetails.aspx?tid=81
    Google Scholar
  • 14 ECASS-III .Placebo controlled trial of alteplase (rt-PA) in acute ischemic hemispheric stroke where thrombolysis is initiated between 3 and 4 hours after stroke onset. In: Goldberg MP (ed) Stroke Trials Directory. Internet Stroke Center web site. 07-Aug-2006: http://www.strokecenter.org/trials/TrialDetails.aspx?tid=475
    Google Scholar
  • 15 Echoplanar imaging thrombolysis evaluation trial (EPITHET). In: Goldberg MP (ed) Stroke Trials Directory. Internet Stroke Center web site. 07-Aug-2006: http://www.strokecenter.org/trials/TrialDetails.aspx?tid=420
    Google Scholar
  • 16 Hacke W, Albers G, Al-Rawi Y. et al . The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase.  Stroke. 2005;  36 66-73
    CrossrefPubMedGoogle Scholar
  • 17 Desmoteplase in acute ischemic stroke (DIAS-2). In: Goldberg MP (ed) Stroke Trials Directory. Internet Stroke Center web site. 07-Aug-2006: http://www.strokecenter.org/trials/TrialDetails.aspx?tid=515
    Google Scholar
  • 18 Ancrod Stroke Program (ASP-II): Ancrod (Viprinex) for the treatment of acute ischemic stroke. In: Goldberg MP (ed) Stroke Trials Directory. Internet Stroke Center web site. 07-Aug-2006: http://www.strokecenter.org/trials/TrialDetails.aspx?tid=701
    Google Scholar
  • 19 ASP-I. Ancrod (Viprinex) for the treatment of acute ischemic stroke. In: Goldberg MP (ed) Stroke Trials Directory. Internet Stroke Center web site. 07-Aug-2006: http://www.strokecenter.org/trials/TrialDetails.aspx?tid=655
    Google Scholar
  • 20 Study of efficacy of tirofiban in acute ischemic stroke (SETIS). In: Goldberg MP (ed) Stroke Trials Directory. Internet Stroke Center web site. 07-Aug-2006: http://www.strokecenter.org/trials/TrialDetails.aspx?tid=540
    Google Scholar
  • 21 Zoppo G J Del, Higashida R T, Furlan A J. et al. and the PROACT Investigators . PROACT: A phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke.  Stroke. 1998;  29 4-11
    CrossrefPubMedGoogle Scholar
  • 22 Furlan A, Higashida R, Wechsler L. et al., for the PROACT Investigators . Intra-arterial prourokinase for acute ischemic stroke - The PROACT II Study: A randomized controlled trial.  JAMA. 1999;  282 2003-2011
    CrossrefPubMedGoogle Scholar
  • 23 Lewandowski C, Frankel M, Tomsick T. et al., and the EMS brigding trial investigators . Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke - Emergency Management of STroke (EMS) brigding trial.  Stroke. 1999;  30 2598-2605
    CrossrefPubMedGoogle Scholar
  • 24 Local versus systemic thrombolysis for acute stroke (SYNTHESIS). In: Goldberg MP (ed) Stroke Trials Directory. Internet Stroke Center web site. 07-Aug-2006: http://www.strokecenter.org/trials/TrialDetails.aspx?tid=521
    Google Scholar
  • 25 Imaging-based thrombolysis trial in acute ischemic stroke (ITAIS). In: Goldberg MP (ed) Stroke Trials Directory. Internet Stroke Center web site. 07-Aug-2006: http://www.strokecenter.org/trials/TrialDetails.aspx?tid=680
    Google Scholar
  • 26 MCA-embolism local fibrinolytic intervention trial (MELT). In: Goldberg MP (ed) Stroke Trials Directory. Internet Stroke Center web site. 07-Aug-2006: http://www.strokecenter.org/trials/TrialDetails.aspx?tid=589
    Google Scholar
  • 27 Mechanical embolus removal in cerebral ischemia (Multi MERCI). In: Goldberg MP (ed) Stroke Trials Directory. Internet Stroke Center web site. 07-Aug-2006: http://www.strokecenter.org/trials/TrialDetails.aspx?tid=675
    Google Scholar
  • 28 MR and recanalization of stroke clots using embolectomy (MR RESCUE). In: Goldberg MP (ed) Stroke Trials Directory. Internet Stroke Center web site. 07-Aug-2006: http://www.strokecenter.org/trials/TrialDetails.aspx?tid=559
    Google Scholar
  • 29 Lees K R, Zivin J A, Ashwood T. et al . NXY-059 for acute ischemic stroke.  N Engl J Med. 2006;  354 588-600
    CrossrefPubMedGoogle Scholar
  • 30 SAINT II. Stroke - Acute Ischemic - NXY-059 (Cervovive) Treatment. In: Goldberg MP (ed) Stroke Trials Directory. Internet Stroke Center web site. 07-Aug-2006: http://www.strokecenter.org/trials/TrialDetails.aspx?tid=611
    Google Scholar
  • 31 Thomalla G, Schwark C, Sobesky J. et al . Outcome and symptomatic bleeding complications of intravenous thrombolysis within 6 hours in MRI-selected stroke patients: comparison of a German multicenter study with the pooled data of ATLANTIS, ECASS, and NINDS tPA trials.  Stroke. 2006;  37 852-858
    CrossrefPubMedGoogle Scholar
  • 32 Ribo M, Molina C A, Rovira A. et al . Safety and efficacy of intravenous tissue plasminogen activator stroke treatment in the 3- to 6-hour window using multimodal transcranial Doppler/MRI selection protocol.  Stroke. 2005;  36 602-606
    CrossrefPubMedGoogle Scholar

PD Dr. C. Weimar

Klinik für Neurologie, Universitätsklinikum Essen

Hufelandstraße 55

45122 Essen

eMail: stroke.med@uni-essen.de